Literature DB >> 18987935

Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma.

Satoru Seo1, Ryuichiro Doi, Takafumi Machimoto, Kazuhiro Kami, Toshihiko Masui, Etsuro Hatano, Kohei Ogawa, Tatsuya Higashi, Shinji Uemoto.   

Abstract

BACKGROUND/
PURPOSE: Pancreatic carcinoma has a poor prognosis, and early detection is essential to allow potentially curative resection. Despite the wide array of diagnostic tools available, the detection of small pancreatic tumors remains difficult. The aim of this study was to investigate the contribution of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) to the diagnosis of early pancreatic cancer.
METHODS: FDG-PET was performed in 56 patients with pancreatic cancer who underwent curative surgery. The standardized uptake value (SUV) for FDG was calculated in each patient and the relationships between the SUV and various clinicopathological factors were analyzed.
RESULTS: The tumors ranged from 0.8 to 6.5 cm in diameter. When the cutoff value for the SUV was set at 2.5, 51 of the 56 patients (91%) had a positive FDG-PET study. The SUV did not show a significant difference in relation to tumor differentiation or pTS and pT factors. There was also no correlation between the SUV and the maximum tumor diameter (r = 0.22; P = 0.1). Five tumors had an SUV below the cutoff value, and all of these lesions had intermediate or scirrhous stroma rather than medullary stroma.
CONCLUSIONS: These results indicate that FDG-PET is useful for the detection of small early pancreatic cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987935     DOI: 10.1007/s00534-007-1339-x

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  11 in total

1.  Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.

Authors:  Hisashi Imai; Ryuichiro Doi; Hiroyuki Kanazawa; Naoko Kamo; Masayuki Koizumi; Toshihiko Masui; Yasuhiro Iwanaga; Yoshiya Kawaguchi; Yasutsugu Takada; Hiroyoshi Isoda; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2010-03-16       Impact factor: 3.402

2.  Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection.

Authors:  Kojun Okamoto; Isamu Koyama; Mitsuo Miyazawa; Yasuko Toshimitsu; Masayasu Aikawa; Katsuya Okada; Etsuko Imabayashi; Hiroshi Matsuda
Journal:  Int J Clin Oncol       Date:  2010-09-23       Impact factor: 3.402

3.  Pilot study: Evaluation of dual-energy computed tomography measurement strategies for positron emission tomography correlation in pancreatic adenocarcinoma.

Authors:  Jorge Oldan; Miao He; Teresa Wu; Alvin C Silva; Jing Li; J Ross Mitchell; William M Pavlicek; Michael C Roarke; Amy K Hara
Journal:  J Digit Imaging       Date:  2014-12       Impact factor: 4.056

4.  Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.

Authors:  Peter Einersen; Irene Epelboym; Megan D Winner; David Leung; John A Chabot; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2014-06-14       Impact factor: 3.452

Review 5.  Surveillance for neoplasia in the pancreas.

Authors:  Kasper A Overbeek; Djuna L Cahen; Marcia Irene Canto; Marco J Bruno
Journal:  Best Pract Res Clin Gastroenterol       Date:  2016-11-05       Impact factor: 3.043

Review 6.  Diagnostic strategies for early pancreatic cancer.

Authors:  Keiji Hanada; Akihito Okazaki; Naomichi Hirano; Yoshihiro Izumi; Yuji Teraoka; Juri Ikemoto; Kozue Kanemitsu; Fumiaki Hino; Toshikatsu Fukuda; Shuji Yonehara
Journal:  J Gastroenterol       Date:  2014-12-14       Impact factor: 7.527

7.  18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer.

Authors:  Keiichi Okano; Keitaro Kakinoki; Shintaro Akamoto; Masanobu Hagiike; Hisashi Usuki; Yuka Yamamoto; Yoshihiro Nishiyama; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

Review 8.  The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer.

Authors:  Kai Luo; Xiangkun Wang; Xudong Zhang; Zhongyuan Liu; Shuai Huang; Renfeng Li
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

9.  Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Authors:  Paul F Laeseke; Ru Chen; R Brooke Jeffrey; Teresa A Brentnall; Jürgen K Willmann
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

Review 10.  Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review.

Authors:  Khaled Y Elbanna; Hyun-Jung Jang; Tae Kyoung Kim
Journal:  Insights Imaging       Date:  2020-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.